We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERY icon
2776
Direxion Daily Energy Bear 2X ETF
ERY
$35.4M
$24.7K ﹤0.01%
1,200
-34,583
-97% -$788K
QNTM
2777
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$24.6K ﹤0.01%
+3,195
New +$18.4K
MYGN icon
2778
Myriad Genetics
MYGN
$290M
$24.5K ﹤0.01%
2,763
-25,501
-90% -$306K
LEG icon
2779
Leggett & Platt
LEG
$1.32B
$24.5K ﹤0.01%
3,135
-35,968
-92% -$341K
ALAB icon
2780
Astera Labs
ALAB
$55.8B
$24.5K ﹤0.01%
410
-3,066
-88% -$284K
KFRC icon
2781
Kforce
KFRC
$1.04B
$24.4K ﹤0.01%
500
-618
-55% -$32.2K
GLRE icon
2782
Greenlight Captial
GLRE
$514M
$24.4K ﹤0.01%
1,804
+1,347
+295% +$18.3K
MBOT icon
2783
Microbot Medical
MBOT
$104M
$24.4K ﹤0.01%
16,173
+11,767
+267% +$20.8K
AMRX icon
2784
Amneal Pharmaceuticals
AMRX
$6.32B
$24.4K ﹤0.01%
2,913
+1,136
+64% +$9.48K
BY icon
2785
Byline Bancorp
BY
$1.78B
$24.4K ﹤0.01%
931
-1,122
-55% -$31.5K
EXFY icon
2786
Expensify
EXFY
$210M
$24.3K ﹤0.01%
8,008
-2,826
-26% -$9.82K
PARAA
2787
DELISTED
Paramount Global Class A
PARAA
$24.3K ﹤0.01%
1,069
+403
+61% +$9.13K
AORT icon
2788
Artivion
AORT
$1.42B
$24.3K ﹤0.01%
988
-1,142
-54% -$31.7K
WASH icon
2789
Washington Trust Bancorp
WASH
$767M
$24.3K ﹤0.01%
786
-1,562
-67% -$49.5K
BF.A icon
2790
Brown-Forman Class A
BF.A
$13.3B
$24.2K ﹤0.01%
723
-6,183
-90% -$208K
TRNS icon
2791
Transcat
TRNS
$877M
$24.2K ﹤0.01%
325
-245
-43% -$20.5K
TIL icon
2792
Instil Bio
TIL
$50.1M
$24.2K ﹤0.01%
1,392
-18
-1% -$373
SRTA
2793
Strata Critical Medical Inc
SRTA
$522M
$24.1K ﹤0.01%
8,844
+5,969
+208% +$21.4K
ECO
2794
Okeanis Eco Tankers
ECO
$2.35B
$24.1K ﹤0.01%
1,090
+599
+122% +$13.7K
AMLX icon
2795
Amylyx Pharmaceuticals
AMLX
$2.41B
$24.1K ﹤0.01%
6,803
-39,184
-85% -$139K
LFST icon
2796
Lifestance Health
LFST
$4.75B
$24.1K ﹤0.01%
3,614
+713
+25% +$5.42K
AMAL icon
2797
Amalgamated Financial
AMAL
$1.53B
$24.1K ﹤0.01%
837
-6,380
-88% -$209K
REX icon
2798
REX American Resources
REX
$1.47B
$24K ﹤0.01%
1,280
-836
-40% -$16.8K
FULC icon
2799
Fulcrum Therapeutics
FULC
$285M
$24K ﹤0.01%
8,332
+4,357
+110% +$16K
PSIX
2800
Power Solutions International
PSIX
$935M
$24K ﹤0.01%
949
+924
+3,696% +$31.9K

Similar funds

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.